SSTR5 and hydrops fetalis: A detailed in silico analysis on failing and healthy human hearts has demonstrated that cardiac GPCRs encoded by the F2rl2 and Sstr5 genes could serve as novel and potential biomarkers or therapeutic targets of HF [56], similarly to our findings identified by ddPCR.